CYP 6.38% 25.0¢ cynata therapeutics limited

Ann: Final Preclinical Asthma Study Confirms Efficacy, page-11

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 178 Posts.
    Just on Channel 9 News Melbourne.

    Stated that they expect a human clinical trial for Asthma next year, and a product to be on the shelves by 2021.
    Last edited by AdamM-V: 11/12/17
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.